MEwens
Marketing Probe: Merck has been subpoenaed by the Justice Department as part of a criminal probe into the marketing and sales of three drugs since 2004, the WSJ reports. Temodar, PegIntron and Intron A were Schering-Plough products; Merck acquired the company in 2009. Merck is cooperating with the investigation, a spokesman tells […]
Continued Read ...
MEwens
High-tech is not necessarily better.
That point was reinforced by a study published yesterday by the Journal of the National Cancer Institute. It found that computer-aided detection technology, intended to help radiologists interpret mammograms, is associated with more false-positive findings but doesn’t help detect more cancers.
This study covers 1.6 million mammograms done at 90 […]
Continued Read ...
MEwens
Last fall researchers announced that a government-funded trial found screening current and former heavy smokers with low-dose CT scans reduced lung-cancer deaths by 20%. And yesterday, the details of that research were published in the New England Journal of Medicine.
But the groundbreaking findings don’t mean that cancer groups have yet embraced a widespread […]
Continued Read ...
MEwens
What’s Essential?: Regulators are working on definitions of the “essential” medical care that must be offered by insurance plans under the health-care overhaul law, the WSJ reports. The law defines ten categories of care that must be provided, but the specifics are sparking debate — for example, which so-called habilitative services, such as […]
Continued Read ...
MEwens
Also: looking into radiosurgery equipment; Pepsi’s new snack; salmonella hits sprouts, cilantro and parsley.
Read more this great post here
Continued Read ...
Katherine Hobson
After the three annual screens, 24.2% of participants screened with CT had gotten a positive finding at some point along the way, compared to 6.9% of those in the X-ray arm.
Read more this great post here
Continued Read ...
Katherine Hobson
A new study finds almost 40% of 1,426 research imaging exams had an incidental finding.
Read more this great post here
Continued Read ...
Katherine Hobson
Also: study quantifies radiation from nuclear imaging tests; Genzyme and Sanofi talk price; routine care coverage for clinical trial participants.
Read more this great post here
Continued Read ...
MEwens
Bayer and GE are also developing diagnostic compounds to be used in tandem with imaging.
Read more this great post here
Continued Read ...
Katherine Hobson
Also: new safeguards on medical radiation; a research project will disclose some genetic data to participants; overweight firefighters in Boston.
Read more this great post here
Continued Read ...
